Here is an article about Piramal Pharma’s sustainability report, written in a polite tone and incorporating relevant information from the provided (hypothetical) PR Newswire release:
Piramal Pharma Unveils FY25 Sustainability Report, Highlighting Performance and Decarbonation Journey
Mumbai, India – August 26, 2025 – Piramal Pharma Limited (PPL), a prominent player in the pharmaceutical industry, has proudly released its Sustainability Report for the Financial Year 2025. This comprehensive report offers a transparent overview of the company’s performance in environmental, social, and governance (ESG) areas, with a particular focus on its dedicated decarbonization trajectory.
The report, published on August 26, 2025, underscores Piramal Pharma’s steadfast commitment to integrating sustainability into its core business strategies and operations. It provides stakeholders with detailed insights into the progress made and the initiatives undertaken to foster responsible growth and minimize environmental impact.
A key highlight of the FY25 report is the detailed account of Piramal Pharma’s ongoing efforts in decarbonization. The company outlines its strategic roadmap and tangible actions aimed at reducing its carbon footprint across its various facilities and value chain. This includes investments in renewable energy sources, improvements in energy efficiency, and the adoption of sustainable manufacturing practices.
Furthermore, the report elaborates on Piramal Pharma’s broader sustainability performance, encompassing social responsibility and robust governance structures. This includes updates on employee welfare, community engagement programs, and ethical business conduct. The company emphasizes its dedication to creating a positive impact on the communities it serves and upholding the highest standards of corporate governance.
Piramal Pharma views sustainability not merely as a compliance requirement but as a fundamental driver of long-term value creation. By transparently sharing its progress and future aspirations, the company aims to engage with its stakeholders, including investors, customers, employees, and the wider community, fostering collaboration and shared responsibility in building a more sustainable future.
The full Sustainability Report for FY25 is available for review, offering a detailed exploration of Piramal Pharma’s commitment to excellence in sustainability and its proactive approach to addressing global environmental challenges.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Policy Public Interest published ‘Piramal Pharma publie son rapport sur le développement durable pour l’exercice 2025, décrivant ses performances et sa trajectoire de décarbonation’ at 2025-08-26 17:56. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.